Because of the instrumental role of the CD95-mediated apoptotic signal in anti-infectious and anti-tumor responses, we assumed that inhibiting CD95 non-apoptotic responses while conserving the apoptotic signal could be an attractive therapeutic option for preventing Th17 recruitment in inflamed organs without altering immune surveillance. Here, FAS is linked to neoplasm.